See more : Ember Therapeutics, Inc. (EMBT) Income Statement Analysis – Financial Results
Complete financial analysis of Anli International Co., Ltd. (5223.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Anli International Co., Ltd., a leading company in the Manufacturing – Metal Fabrication industry within the Industrials sector.
- Cell Source, Inc. (CLCS) Income Statement Analysis – Financial Results
- Chemring Group PLC (CMGMY) Income Statement Analysis – Financial Results
- Teck Resources Limited (TECK-B.TO) Income Statement Analysis – Financial Results
- Acer Cyber Security Inc. (6690.TWO) Income Statement Analysis – Financial Results
- Dlaboratory Sweden AB (publ) (DLAB.ST) Income Statement Analysis – Financial Results
Anli International Co., Ltd. (5223.TWO)
About Anli International Co., Ltd.
Anli International Co., Ltd., together with its subsidiaries, engages in the stamping of various precision metals in China and Taiwan. The company manufactures and sells die casting components, computers, communication equipment, vehicle components, precision metalworking products, and new electronic components, such as inductance and metal finishing; and designs, research, and develops metal materials, machine parts, computer software, and fine blanking die products. It offers CNC processing, 3C products, automotive products, optical communication products, vision system application products, household products, and other products. The company serves the computers, communications, and consumer electronics industries. Anli International Co., Ltd. was incorporated in 2010 and is headquartered in Grand Cayman, the Cayman Islands.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.53B | 2.06B | 2.28B | 2.08B | 1.47B |
| Cost of Revenue | 1.21B | 1.53B | 1.65B | 1.37B | 1.02B |
| Gross Profit | 313.15M | 531.47M | 625.47M | 707.34M | 451.22M |
| Gross Profit Ratio | 20.53% | 25.80% | 27.49% | 34.08% | 30.62% |
| Research & Development | 71.84M | 79.29M | 69.27M | 46.68M | 39.74M |
| General & Administrative | 182.00M | 184.59M | 194.76M | 192.56M | 162.07M |
| Selling & Marketing | 66.22M | 73.30M | 74.39M | 59.12M | 66.39M |
| SG&A | 248.22M | 257.88M | 269.15M | 251.68M | 228.90M |
| Other Expenses | -6.90M | 37.79M | -1.77M | -41.59M | 0.00 |
| Operating Expenses | 313.15M | 337.17M | 338.42M | 298.36M | 268.64M |
| Cost & Expenses | 1.53B | 1.87B | 1.99B | 1.67B | 1.29B |
| Interest Income | 10.21M | 27.86M | 18.70M | 4.40M | 6.44M |
| Interest Expense | 15.57M | 18.29M | 10.05M | 5.20M | 3.97M |
| Depreciation & Amortization | 113.62M | 120.84M | 126.04M | 114.02M | 86.86M |
| EBITDA | 130.91M | 380.79M | 430.03M | 485.81M | 269.45M |
| EBITDA Ratio | 8.58% | 18.49% | 18.90% | 23.41% | 18.29% |
| Operating Income | 17.36M | 259.95M | 303.99M | 371.79M | 182.58M |
| Operating Income Ratio | 1.14% | 12.62% | 13.36% | 17.92% | 12.39% |
| Total Other Income/Expenses | -15.54M | 47.36M | 6.89M | -42.39M | -997.00K |
| Income Before Tax | 1.82M | 241.84M | 293.93M | 366.15M | 181.59M |
| Income Before Tax Ratio | 0.12% | 11.74% | 12.92% | 17.64% | 12.32% |
| Income Tax Expense | 5.52M | 45.87M | 62.76M | 82.66M | 27.28M |
| Net Income | -3.70M | 195.97M | 231.17M | 283.48M | 154.31M |
| Net Income Ratio | -0.24% | 9.52% | 10.16% | 13.66% | 10.47% |
| EPS | -0.08 | 4.40 | 5.22 | 6.56 | 3.57 |
| EPS Diluted | -0.08 | 4.06 | 4.81 | 6.41 | 3.55 |
| Weighted Avg Shares Out | 44.55M | 44.55M | 44.31M | 43.21M | 43.47M |
| Weighted Avg Shares Out (Dil) | 44.55M | 49.36M | 49.09M | 44.23M | 43.50M |
Source: https://incomestatements.info
Category: Stock Reports